Rapid Medical

Neurovascular Devices

Health Tech & Life Sciences
Active
Series D Yokne'am Illit, Israel Founded 2008
Last updated 2026-06-18
Total raised
$82.3M
Last: 2024-10
Stage
Series D
Founded
2008
Headcount
144
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

Rapid Medical develops safe and effective neurovascular medical devices designed to benefit patients while meeting the needs of physicians. Its products include distal access catheters and adjustable remodeling mesh for microcatheters. The company is committed to advancing patient care by providing reliable, easy-to-use, high-quality products supported by clinical data.

Rapid Medicals Tigertriever 13 is a CE-marked small-profile stentriever designed to safely retrieve clots from intracranial vessels of 1 mm to 2.5 mm. Its Comaneci device is an FDA 510(k)-cleared adjustable, fully visible aneurysm-remodeling device intended to act as a temporary bridge to aid in the coiling process and minimize the risk of coil protrusion or prolapse.

The companys Drivewire (named Columbus outside the U.S.) is an FDA-cleared guidewire with a steerable distal tip that handles complex anatomical turns with ease. With Drivewire, physicians control the direction and shape of the guidewires tip while it is inside the vessel, precisely navigating the neuro and peripheral vasculature. This intravascular steering provides access to difficult anatomical locations, increasing the physicians ability to treat vascular diseases with less invasive interventional approaches.

Funding history · 7 rounds · $82.3M total

Q&A

What is Rapid Medical's primary business?
Rapid Medical develops neurovascular medical devices, including distal access catheters and adjustable remodeling mesh for microcatheters, designed to benefit patients and meet physician needs.
When was Rapid Medical founded?
Rapid Medical was founded in August 2008.
How many employees does Rapid Medical have?
Rapid Medical has 51-200 employees.
What is the total amount of funding Rapid Medical has raised to date?
Rapid Medical has raised a total of $82.31 million USD.
Which investors participated in Rapid Medical's May 2021 funding round?
In May 2021, Rapid Medical received funding from Shanghai MicroPort CardioFlow Medtech and Deep Insight.
What is the latest funding event recorded for Rapid Medical?
Rapid Medical received funding in October 2024 from Titan Capital Partners.
Who are the co-founders of Rapid Medical?
The co-founders of Rapid Medical are Shimon Eckhouse, who serves as Co-founder & Chairman of The Board, and Ronen Eckhouse, who serves as Co-founder & CEO.
What is the Comaneci device developed by Rapid Medical?
Rapid Medical's Comaneci device is an FDA 510(k)-cleared adjustable, fully visible aneurysm-remodeling device intended to act as a temporary bridge to aid in the coiling process and minimize the risk of coil protrusion or prolapse.

Team · 2

Founder · Co-founder & Chairman of The Board
LinkedIn ↗
Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

cathetersstrokeneurovascularmedical-devicesvascularminimally-invasivetreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)